This practice bulletin provides evidence-based recommendations for the diagnosis and clinical management of polycystic ovary syndrome, including consideration of metabolic and cardiovascular risks.
Supports metabolic screening in PCOS; leaves open optimal long-term strategies.
Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Its etiology remains unknown, and treatment is largely symptom based and empirical. PCOS has the potential to cause substantial metabolic sequelae, including an increased risk of diabetes and cardiovascular disease, and these factors should be considered when determining long-term treatment. The purpose of this document is to examine the best available evidence for the diagnosis and clinical management of PCOS.
No takes yet. Share an insight, caveat, or question.
A 2018 study studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: